European Congress of Immunology

Glasgow, Scotland | 5 - 8 September, 2012

Satellite Symposia

A number of Industry sponsored Satellite Symposia will be taking place across the 4 days of the ECI Congress.  They are an integral part of the Congress programme and as such are free for delegates to attend.  Please check this page regularly as it will be updated as new Symposia are confirmed.

STEMCELL TECHNOLOGIES – “Development and Activation of Human Immune Cells”

Wednesday, 4 September 2012 from 15:00 to 16:30

Location: Forth

Speakers
Esperanza Perucha
, PhD, Centre for Molecular & Cellular Biology of Inflammation, COPE lab, King’s College London - Understanding the role of the Retinoic-acid related orphan receptor (ROR)c2 in human CD4+ T cell
Eva Brencicova, PhD Student, Immunobiology Dept. Division of Immunology, King’s College London - Activation of dendritic cells with Toll-like receptor agonists for immunotherapy in ovarian carcinoma

 

UNILEVER – “Mathematical modelling in immunology: Focus on T cell responses”

Thursday, 6 September 2012 from 12:45 to 14:00

Location: Dochart

Chair
Carmen Molina-París,
Professor in Applied Mathematics, University of Leeds, UK - Stochastic modelling of T cell responses

Speakers
Michael Davies, Mathematical modeller, Unilever Safety and Environmental Assurance Centre, UK - Skin allergy: Modelling the T cell response
Deborah Dunn-Walters, Reader in Immunology, King’s College London – B cell repertoire: individual variance and detection of immune responses
Benedict Seddon, Programme leader, MRC National Institute for Medical Research – Why do we have more CD4 than CD8 T cells? Insights from quantitative models

 

WELLCOME TRUST – “Immunology funding at the Wellcome Trust”

Thursday, 6 September 2012 from 12:45 to 14:00

Location: Boisdale 1

Speakers
Danny Altmann
, Wellcome Trust - An informal session to introduce, discuss and answer queries on current Wellcome funding schemes for infection and immunity research, including fellowships and investigator awards.

 

PFIZER – “Appliance of immunology to disease”

Thursday, 6 September 2012 from 12:45 to 14:00

Location: Lomond Auditorium

Chair
Professor Iain McInnes
, Professor of Experimental Medicine and Rheumatology, University of Glasgow, Scotland

Speakers
Professor Iain McInnes
, Professor of Experimental Medicine and Rheumatology, University of Glasgow, Scotland
Professor Peter Taylor, Professor of Experimental Rheumatology at the Kennedy Institute, Oxford, UK
Professor Georg Schett, Chief of Rheumatology, University of Erlangen-Nuremberg, Germany

 

Time

Presentation

Speaker

12:45–12:50

Arrival and refreshments

 

12:50–12:55

Welcome and introduction

Professor Iain McInnes

12:55–13:10

Current pathogenesis – clinical to molecular phenotype

Professor Iain McInnes

13:10–13:30

Lessons from pathogenesis and biologics

Professor Peter Taylor

13:30–13:50

Small molecule kinase inhibition – New strategies to inhibit autoimmune inflammatory disease

Professor Georg Schett

13:50–14:00

Q&A

Summary and close

All

Professor Iain McInnes

 

 

 

 

 

 

 Please click here to download the Pfizer Satellite Symposia invitation

 

LFB BIOTECHNOLOGIES – “The immunomodulatory activities of therapeutic antibodies, from preclinical studies to clinical trials”

Friday, 7 September 2012 from 17.15 to 19.30

Location: Morar

Chairs
Pr W.Herman Fridman, Cordeliers Research Center, Inserm UMR 872, Paris, France

Speakers 
Pr Mark Smyth, Peter McCallum Cancer Center, East Melbourne, Australia – Immunomodulatory antibodies in cancer : lessons from animal models 
Dr Christophe de Romeuf, LFB, Les Ulis, France – Discovery and development of EMABling® glycoengineered antibodies for clinical use : a review  
Dr Jean-Luc Teillaud, Cordeliers Research Center, Inserm UMR 872, Paris, France – Long-lasting antitumor protection by anti-CD20 antibody through adaptive cellular immune response
Pr James P. Allison, Ludwig Institute, Memorial Sloan-Kettering Cancer Center, New York, USA. – Modulators of immunosuppression, from rationale to clinical use 
Pr W.Herman Fridman, Inserm UMR 872, Paris, France – Concluding remarks
Dr Sami Chtourou, LFB, Les Ulis, France – Concluding remarks

Please click here to download the draft LFB Symposia Programme.

 

 

 

The details above are subject to change and will be updated as new Symposia are confirmed.